SCHEMBL8250205

SCHEMBL8250205

CC(=O)CN=C(c1ccccc1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
HSD17B10 Q99714 1/20 0.55
CES1 P23141 5/20 0.45
CES2 O00748 4/20 0.45
ALDH1A1 P00352 9/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
RAB9A P51151 2/20 0.42
MAPT P10636 3/20 0.41
MAPK1 P28482 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP3A4 P08684 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
POLB P06746 1/20 0.41
TSHR P16473 2/20 0.41
DAO P14920 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19524692 0.84 CYP1A2 (0.45) CYP1A2CYP2D6HSD17B10ALDH1A1SMN1; SMN2
SCHEMBL17003209 0.83 HSD17B10 (0.64) CYP1A2CYP2D6HSD17B10CES1CES2
SCHEMBL693428 0.83 HSD17B10 (0.64) CYP1A2CYP2D6HSD17B10CES1CES2
SCHEMBL5998675 0.79 L3MBTL1 (0.48) CYP1A2CYP2D6HSD17B10CES1CES2
SCHEMBL478673 0.79 TSHR (0.48) CYP1A2CYP2D6HSD17B10CES1ALDH1A1
SCHEMBL17003212 0.78 PRSS1 (0.44) CYP1A2CYP2D6HSD17B10CES1CES2
SCHEMBL18931501 0.76 CYP1A2 (0.43) CYP1A2CYP2D6HSD17B10CES1CES2
SCHEMBL22016920 0.76 HSD17B10 (0.43) CYP1A2CYP2D6HSD17B10CES1CES2
SCHEMBL17723 0.76 GAA (0.52) CYP1A2CYP2D6HSD17B10ALDH1A1SMN1; SMN2
SCHEMBL13398132 0.75 CYP1A2 (0.42) CYP1A2CYP2D6HSD17B10CES1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180170938-A1 BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2018-06-21 US disclosed
US-20150080598-A1 ASYMMETRIC SYNTHESIS FOR PREPARING FLUOROLEUCINE ALKYL ESTERS MERCK SHARP & DOHME CORP 2015-03-19 US disclosed
US-8937184-B2 1H-imidazole derivatives as cannabinoid CB2 receptor modulators ABBVIE B.V. (NL) 2015-01-20 US disclosed
US-8716524-B2 Optically active quaternary ammonium salt having axial asymmetry and process for producing a-amino acid and derivative thereof with the same NAGASE & CO., LTD (JP) 2014-05-06 US disclosed
US-8586765-B2 Process for the synthesis of 3-amino-3-cyclobuthylmethyl-2-hydroxypropionamide or salts thereof MERCK SHARP & DOHME CORP. (US) 2013-11-19 US disclosed
US-8586570-B2 Sox-based kinase sensor MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2013-11-19 US disclosed
US-8344029-B2 Substituted propanamide derivative and pharmaceutical composition containing the same DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-01-01 US disclosed
US-8110680-B2 Optically active quaternary ammonium salt having axial asymmetry, and method for producing alpha-amino acid and derivative thereof by using the same NAGASE & CO., LTD. (JP) 2012-02-07 US disclosed
US-20110281290-A1 SOX-BASED KINASE SENSOR MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2011-11-17 US disclosed
US-8019550-B2 Drug discovery method Keddem Bioscience Ltd. (IL) 2011-09-13 US disclosed
US-20090270614-A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME NAGASE & CO., LTD. (JP) 2009-10-29 US disclosed
US-7595419-B2 Process and intermediates for the preparation of 3-(amino)-3-cyclobutylmethyl-2-hydroxy-propionamide or salts thereof SCHERING CORPORATION (US) 2009-09-29 US disclosed
US-7429674-B2 Process for preparing fluoroleucine alkyl esters MERCK & CO. INC.. (US) 2008-09-30 US disclosed
US-20080085894-A1 ALPHA-(N-SULFONAMIDO)ACETAMIDE DERIVATIVES AS BETA-AMYLOID INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2008-04-10 US disclosed
US-20080050761-A1 Sox-based kinase sensor MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2008-02-28 US disclosed
US-7326795-B2 Process and intermediates for the preparation of (1R,2S,5S)-3-azabicyclo[3,1,0]hexane-2-carboxamide, N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2S)-2-[[[1,1-dimethylethyl]amino]carbonylamino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl SCHERING CORPORATION (US) 2008-02-05 US disclosed
US-7312230-B2 Carboxylic acid derivatives as IP antagonists ROCHE PALO ALTO LLC (US) 2007-12-25 US disclosed
US-20070161624-A1 Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same KISHIDA CHEMICAL CO., LTD. (JP) 2007-07-12 US disclosed
US-20070135654-A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING alpha-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME NAGASE & CO., LTD (JP) 2007-06-14 US disclosed
US-20070043234-A1 Use of functionalized onium salts as a soluble support for organic synthesis CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2007-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135654-A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING alpha-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME BCAT1, BCAT2, AADAT CYP1A2 2680/4885CYP2D6 3472/4885HSD17B10 1671/4885
US-20080085894-A1 ALPHA-(N-SULFONAMIDO)ACETAMIDE DERIVATIVES AS BETA-AMYLOID INHIBITORS APP, APBA1, BACE1 CYP1A2 3396/4885CYP2D6 4488/4885HSD17B10 3525/4885
US-20070043234-A1 Use of functionalized onium salts as a soluble support for organic synthesis NOS1, NOS2, F12 CYP1A2 363/4885CYP2D6 1940/4885HSD17B10 3522/4885
US-20080050761-A1 Sox-based kinase sensor SOX18, HIPK1, HIPK3 CYP1A2 4826/4885CYP2D6 4807/4885HSD17B10 2064/4885
US-20090270614-A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME BCAT1, BCAT2, AADAT CYP1A2 1393/4885CYP2D6 2715/4885HSD17B10 1492/4885
US-20180170938-A1 BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS CFTR, P2RY2, P2RX5 CYP1A2 1557/4885CYP2D6 1933/4885HSD17B10 4676/4885
US-20150080598-A1 ASYMMETRIC SYNTHESIS FOR PREPARING FLUOROLEUCINE ALKYL ESTERS INF2, BCAT1, BCAT2 CYP1A2 710/4885CYP2D6 381/4885HSD17B10 1323/4885
US-20070161624-A1 Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same BCAT1, BCAT2, AADAT CYP1A2 2680/4885CYP2D6 3472/4885HSD17B10 1671/4885
US-20110281290-A1 SOX-BASED KINASE SENSOR SOX18, HIPK1, HIPK3 CYP1A2 4826/4885CYP2D6 4807/4885HSD17B10 2064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.